These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 36209351)
21. Clinical and molecular characteristics of a novel rare Verbinnen I; Procknow SS; Lenaerts L; Reynhout S; Mehregan A; Ulens C; Janssens V; King KA Front Cell Dev Biol; 2022; 10():1059938. PubMed ID: 36531959 [TBL] [Abstract][Full Text] [Related]
22. Identification and functional analyses of polymorphism haplotypes of protein phosphatase 2A-Aα gene promoter. Lin YC; Chen HF; Lin LN; Luo J; Li W; Zhang SJ; Li XJ; Hu YM; Chen YX; Chen W; Lin ZN Mutat Res; 2011 Nov; 716(1-2):66-75. PubMed ID: 21889517 [TBL] [Abstract][Full Text] [Related]
23. Role of a novel functional variant in the PPP2R1A promoter on the regulation of PP2A-Aalpha and the risk of hepatocellular carcinoma. Chen HF; Mai JR; Wan JX; Gao YF; Lin LN; Wang SZ; Chen YX; Zhang CZ; Zhang YJ; Xia B; Liao K; Lin YC; Lin ZN PLoS One; 2013; 8(3):e59574. PubMed ID: 23555712 [TBL] [Abstract][Full Text] [Related]
24. Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical Defects. Duncan AR; Vitobello A; Collins SC; Vancollie VE; Lelliott CJ; Rodan L; Shi J; Seman AR; Agolini E; Novelli A; Prontera P; Guillen Sacoto MJ; Santiago-Sim T; Trimouille A; Goizet C; Nizon M; Bruel AL; Philippe C; Grant PE; Wojcik MH; Stoler J; Genetti CA; van Dooren MF; Maas SM; Alders M; Faivre L; Sorlin A; Yoon G; Yalcin B; Agrawal PB Am J Hum Genet; 2020 Dec; 107(6):1170-1177. PubMed ID: 33232677 [TBL] [Abstract][Full Text] [Related]
25. Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth. Haesen D; Abbasi Asbagh L; Derua R; Hubert A; Schrauwen S; Hoorne Y; Amant F; Waelkens E; Sablina A; Janssens V Cancer Res; 2016 Oct; 76(19):5719-5731. PubMed ID: 27485451 [TBL] [Abstract][Full Text] [Related]
26. Variants in ADD1 cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly in humans. Qi C; Feng I; Costa AR; Pinto-Costa R; Neil JE; Caluseriu O; Li D; Ganetzky RD; Brasch-Andersen C; Fagerberg C; Hansen LK; Bupp C; Muraresku CC; Ruan X; Kang B; Hu K; Zhong R; Brites P; Bhoj EJ; Hill RS; Falk MJ; Hakonarson H; Kahle KT; Sousa MM; Walsh CA; Zhang X Genet Med; 2022 Feb; 24(2):319-331. PubMed ID: 34906466 [TBL] [Abstract][Full Text] [Related]
27. A novel splice site CUL3 variant in a patient with neurodevelopmental delay. Vincent KM; Bourque DK Brain Dev; 2023 Apr; 45(4):244-249. PubMed ID: 36710200 [TBL] [Abstract][Full Text] [Related]
28. Second report of SHMT2 related neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities. Majethia P; Bhat V; Yatheesha BL; Siddiqui S; Shukla A Eur J Med Genet; 2022 Jun; 65(6):104481. PubMed ID: 35398349 [TBL] [Abstract][Full Text] [Related]
29. An in-frame deletion affecting the critical acid loop of PPP2R5D is associated with a neonatal lethal form of PPP2R5D-related neurodevelopmental disorder. Alhajaj G; Lacroix C; Trakadis Y; Garfinkle J; Srour M Am J Med Genet A; 2023 Sep; 191(9):2416-2421. PubMed ID: 37248744 [TBL] [Abstract][Full Text] [Related]
30. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype. Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333 [TBL] [Abstract][Full Text] [Related]
31. Scaffold subunit Aalpha of PP2A is essential for female meiosis and fertility in mice. Hu MW; Wang ZB; Jiang ZZ; Qi ST; Huang L; Liang QX; Schatten H; Sun QY Biol Reprod; 2014 Jul; 91(1):19. PubMed ID: 24899574 [TBL] [Abstract][Full Text] [Related]
32. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features. Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086 [TBL] [Abstract][Full Text] [Related]
33. Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series. Revah-Politi A; Ganapathi M; Bier L; Cho MT; Goldstein DB; Hemati P; Iglesias A; Juusola J; Pappas J; Petrovski S; Wilson AL; Aggarwal VS; Anyane-Yeboa K Am J Med Genet A; 2017 Dec; 173(12):3158-3164. PubMed ID: 28941020 [TBL] [Abstract][Full Text] [Related]
34. 8q21.11 microdeletion syndrome: Delineation of HEY1 as a candidate gene in neurodevelopmental and cardiac defects. Ben Ayed I; Bouzid A; Kammoun F; Souissi A; Jallouli O; Mallouli S; Guidara S; Loukil S; Aloulou H; Jbeli F; Aouichaoui S; Abid D; Abdelhedi F; Triki C; Kamoun H; Masmoudi S Mol Genet Genomic Med; 2021 Nov; 9(11):e1811. PubMed ID: 34549899 [TBL] [Abstract][Full Text] [Related]
35. Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities. Jeanne M; Demory H; Moutal A; Vuillaume ML; Blesson S; Thépault RA; Marouillat S; Halewa J; Maas SM; Motazacker MM; Mancini GMS; van Slegtenhorst MA; Andreou A; Cox H; Vogt J; Laufman J; Kostandyan N; Babikyan D; Hancarova M; Bendova S; Sedlacek Z; Aldinger KA; Sherr EH; Argilli E; England EM; Audebert-Bellanger S; Bonneau D; Colin E; Denommé-Pichon AS; Gilbert-Dussardier B; Isidor B; Küry S; Odent S; Redon R; Khanna R; Dobyns WB; Bézieau S; Honnorat J; Lohkamp B; Toutain A; Laumonnier F Am J Hum Genet; 2021 May; 108(5):951-961. PubMed ID: 33894126 [TBL] [Abstract][Full Text] [Related]
36. PPP2R3C gene variants cause syndromic 46,XY gonadal dysgenesis and impaired spermatogenesis in humans. Guran T; Yesil G; Turan S; Atay Z; Bozkurtlar E; Aghayev A; Gul S; Tinay I; Aru B; Arslan S; Koroglu MK; Ercan F; Demirel GY; Eren FS; Karademir B; Bereket A Eur J Endocrinol; 2019 May; 180(5):291-309. PubMed ID: 30893644 [TBL] [Abstract][Full Text] [Related]
37. [Phenotype and mechanism of inducible ppp2r1a knockout mouse model]. Fan JL; Wang FP; Wang S; Liu XL; Wu XN; Chen W; Chen LP; Li WX Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):530-537. PubMed ID: 29747346 [No Abstract] [Full Text] [Related]
38. Clinical and molecular characterization of de novo loss of function variants in HNRNPU. Leduc MS; Chao HT; Qu C; Walkiewicz M; Xiao R; Magoulas P; Pan S; Beuten J; He W; Bernstein JA; Schaaf CP; Scaglia F; Eng CM; Yang Y Am J Med Genet A; 2017 Oct; 173(10):2680-2689. PubMed ID: 28815871 [TBL] [Abstract][Full Text] [Related]
39. Mutation of PPP2R1A: a new clue in unveiling the pathogenesis of uterine serous carcinoma. Shih IeM; Wang TL J Pathol; 2011 May; 224(1):1-4. PubMed ID: 21432855 [TBL] [Abstract][Full Text] [Related]
40. Genetic contribution to neurodevelopmental outcomes in congenital heart disease: are some patients predetermined to have developmental delay? Rollins CK; Newburger JW; Roberts AE Curr Opin Pediatr; 2017 Oct; 29(5):529-533. PubMed ID: 28719389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]